February 12th 2025
Most children with MIS-C recover within 6 months, with heart function and overall health improving significantly, according to a new study.
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Improving asthma outcomes with a multipronged approach
October 13th 2020Minority children often have worse asthma outcomes than their white peers and many of them attend Head Start preschool programs. An investigation examines whether an intervention including both school and home components improves asthma outcomes.
Can a RSV vaccine administered during pregnancy be effective in preventing infection during infancy?
August 10th 2020A study looks at whether a vaccine for respiratory syncytial virus (RSV) could be effective in reducing RSV-associated, medically significant lower respiratory tract infections in infants.
Multisystem inflammatory syndrome in children associated with COVID-19
July 13th 2020Children who at first did not appear to contract COVID-19 have been found to exhibit a more serious illness that has now been reported worldwide. Two experts offer guidance on recognizing and treating multisystem inflammatory syndrome in children (MIS-C).
The impact of marketing on adolescent vaping behavior
July 3rd 2020Marketing for traditional cigarettes has long been curtailed to stem smoking, but the regulations haven’t always caught up with the marketing needs for vaping. A report examines the impact of promoting vaping on the prevalence of vaping.
How cystic fibrosis can manifest in the gastrointestinal system
February 17th 2020Although the majority of patients with cystic fibrosis (CF) will be managed by specialty care, the primary care provider is often the first line of contact for many routine concerns. When encountering a patient with CF in the primary setting, there are extrapulmonary symptoms that must be considered in patients, which includes gastrointestinal symptoms.
Gastrointestinal manifestations of cystic fibrosis: A primer for pediatricians
February 13th 2020Significant improvements in cystic fibrosis (CF) care have focused primarily on the pulmonary system, but addressing the gastrointestinal complications of CF presents a major opportunity for improvement in disease management.
Fish oil: The promise and the proof
March 28th 2019Certainly, these are interesting times in medicine as the integration of homeopathic remedies and over-the-counter supplements has become increasingly more common in the past few decades. However, with inconsistent medical research and a lack of US Food and Drug Administration regulation, it remains unclear what the most safe and efficacious role these substances will play in the future of medical care.